Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

Prevent an increase in the proportion of macrolide antibiotic-resistant Campylobacter infections — FS‑06

Status: Baseline only

  
Image
Baseline only

Most Recent Data:
2.0 percent (2016-18)

Target:
2.0 percent 1

Desired Direction:
Maintains

Baseline:
2.0 percent of domestically-acquired Campylobacter jejuni infections in humans were resistant to macrolides in 2016-18 2

Prevent an increase in the proportion of domestically-acquired Campylobacter jejuni infections in humans that are resistant to macrolides

Target-Setting Method
Maintain the baseline

Summary

Campylobacter jejuni is one of the major causes of foodborne illness in the United States, and antibiotic treatment is recommended for severe infections. Every year, many people get Campylobacter jejuni infections that are resistant to the macrolide class of antibiotics. Careful use of macrolide antibiotics and strategies that reduce antibiotic-resistant Campylobacter in animals raised for food are critical for preventing macrolide antibiotic-resistant Campylobacter jejuni infections in humans.

Workgroup: Food Safety Workgroup



1. Target has been revised. See Data Methodology and Measurement for more information.

2. Baseline has been revised. See Data Methodology and Measurement for more information.